Betta Pharma unit's BPI-572270 capsules get U.S. FDA approval for tumor trials

Betta Pharmaceuticals Co., Ltd. said its unit's BPI-572270 capsules have received approval from the U.S. Food and Drug Administration to proceed with clinical trials for tumors.